Tag: Daniel Cendan
Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
English
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
Trade secret protection under TSA and IPCAA: Secrecy, value, confidentiality measures and Supreme Court guidance